European Journal of Obstetrics & Gynecology and Reproductive Biology
Volume 136, Issue 2 , Pages 137-145 , February 2008

Effectiveness of health education on Toxoplasma-related knowledge, behaviour, and risk of seroconversion in pregnancy

  • Erica L. Gollub

      Affiliations

    • INSERM, U593, Bordeaux, Université Victor Segalen Bordeaux 2, Institut de Santé Publique, d’Epidémiologie et de Développement (ISPED), Bordeaux, F-33076 Bordeaux cedex, France
    • Corresponding Author InformationCorresponding author. Tel.: +33 5 57 57 13 93; fax: +33 5 56 24 00 81.
    • ,
  • Valériane Leroy

      Affiliations

    • INSERM, U593, Bordeaux, Université Victor Segalen Bordeaux 2, Institut de Santé Publique, d’Epidémiologie et de Développement (ISPED), Bordeaux, F-33076 Bordeaux cedex, France
    • ,
  • Ruth Gilbert

      Affiliations

    • Centre for Paediatric Epidemiology and Biostatistics, Institute of Child Health, 30 Guilford Street, London WC1N 1EH, UK
    • ,
  • Geneviève Chêne

      Affiliations

    • INSERM, U593, Bordeaux, Université Victor Segalen Bordeaux 2, Institut de Santé Publique, d’Epidémiologie et de Développement (ISPED), Bordeaux, F-33076 Bordeaux cedex, France
    • ,
  • Martine Wallon

      Affiliations

    • Service de Parasitologie, Hôpital de la Croix Rousse, 69004 Lyon, France
    • ,
  • the European Toxoprevention Study Group (EUROTOXO)

Received 16 November 2006 ,Revised 16 June 2007 ,Accepted 17 September 2007.

References 

  1. Ambroise-Thomas P, Petersen E. Congenital toxoplasmosis. Scientific background, clinical management and control. Paris: Springer; 2000;
  2. Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet. 2004;363:1965–1976
  3. Joynson D, Wreghitt T. Toxoplasmosis. A comprehensive clinical guide. Cambridge: Cambridge University Press; 2001;
  4. Accessed at: www.cdc.gov/mmwr/preview/mmwrhtml/rr4902a5.htm.
  5. Leroy V. Hadjichristodoulou C for the EUROTOXO group. Systematic review of risk factors of Toxoplasma gondii infection in pregnant women [Unpublished report]. Bordeaux, France. The EUROTOXO Group, October 2005: 21. Downloaded at: http://eurotoxo.isped.u-bordeaux2.fr/WWW_PUBLIC/US-EUROTOXO-PublicAccess-Frame.htm.
  6. Cook AJC, Gilbert RE, Buffolano W, et al. Sources of Toxoplasma infection in pregnant women: European multicenter case–control study. Br Med J. 2000;321:142–147
  7. Jones JL, Ogunmodede F, Scheftel J, et al. Toxoplasmosis-related knowledge and practices among pregnant women in the United States. Infect Dis Obstet Gynecol. 2003;11(3):139–145
  8. Conyn-van Spaendonck MAE, Van Knapen F. Choices in preventive strategies: experience with the prevention of congenital toxoplasmosis in The Netherlands. Scand J Infect Dis Suppl. 1992;84:51–58
  9. National Collaborating Centre for Women's and Children's Health. Antenatal care. Routine care for the healthy pregnant women. Clinical guidelines. London: National Institute for Clinical Excellence; 2003. 286 p.
  10. Baril L, Ancelle T, Goulet V, et al. Risk factors for Toxoplasma infection in pregnancy: a case–control study in France. Scand J Infect Dis. 1999;31:305–309
  11. Jeannel D, Costagliola D, Niel G, et al. What is known about the prevention of congenital toxoplasmosis?. Lancet. 1990;336:359–361
  12. Wallon M, Mallaret MR, Mojon M, et al. Congenital Toxoplasmosis, evaluation of the prevention policy. Presse Med. 1994;23:1467–1470
  13. Foulon W, Naessens A, Ho-Yen D. Prevention of congenital toxoplasmosis. J Perinat Med. 2000;28:337–345
  14. Newton LH, Hall SM. Survey of local policies for prevention of congenital toxoplasmosis. Commun Dis Rep CDR Rev. 1994;4:R121–R124
  15. Ancelle T, Goulet V, Tirard FV, et al. La Toxoplasmose chez la femme enceinte en France en 1995. Resultats d’une enquete nationale perinatale. Bull Epidémiol Hebd. 1996;51:227–229
  16. Breugelmans M, Naessens A, Foulon W. Prevention of toxoplasmosis during pregnancy—an epidemiologic survey over 22 consecutive years. J Perinat Med. 2004;32:211–214
  17. Pawlowski ZS, Gromadecka-Sutkiewicz M, Skommer J, et al. Impact of health education on knowledge and prevention behavior for congenital toxoplasmosis: the experience in Poznan, Poland. Health Educ Res. 2001;16:493–502
  18. Carter AO, Gelmon P, Wells GA, et al. The effectiveness of a prenatal education programme for the prevention of congenital toxoplasmosis. Epidemiol Infect. 1989;103:539–545
  19. Nguyen DT. Masters Recherche Epidemiologie et Biostatistiques: Evolution des connaissances et des comportements au cours d’un programme d’éducation prénatal pour la prévention primaire de la toxoplasmose congénitale chez les femmes enceintes séronégatif pour la toxoplasmose. Région de Lyon, 1994–1995. Juillet 2004.
  20. Wallon M, Nguyen Hoang Hanh DT, Peyron F, et al. Impact of health education for the primary prevention of Toxoplasma infection in pregnancy: lessons from the ERIS study.16th European congress of clinical microbiology and infectious diseases (ECCMID), Nice (France), April 1–4, 2006.
  21. Pocock S. Clinical trials: a practical approach. Chichester: J.W. Sons. Protocol Violations; 1983 (Chapter 12).
  22. Brundage J, Burke D, Gardner L, et al. Tracking the spread of the HIV infection epidemic among young adults in the United States: results of the first four years of screening among civilian applicants for US Military Service. J Acquir Immune Defic Syndr. 1990;3:1168–1180
  23. Ades AE, Nokes DJ. Modeling age- and time-specific incidence from seroprevalence: toxoplasmosis. Am J Epidemiol. 1993;137:1022–1034
  24. Gollub EL, French P, Latka M, et al. Achieving safer sex with choice: testing the women's sexual risk reduction hierarchy in an STD clinic. J Womens Health Gend Based Med. 2001;10:771–783
  25. Kelly JA, St Lawrence JS. The impact of community-based groups to help persons reduce HIV infection behaviors. AIDS Care. 1990;2:25–36
  26. Sikkema KJ. Theoretical basis underlying the community-level approach for initiation and maintenance of HIV risk reduction. Ann Am Acad Political Soc Sci. 2005;599:54–70
  27. Healton CG, Messeri P. The effect of video interventions on improving knowledge and treatment compliance in the sexually transmitted disease clinic setting. Sex Transm Dis. 1993;16:11–21
  28. Albarracin D, Gillette JC, Allison N, et al. A test of major assumptions about behavior change: a comprehensive look at the effects of passive and active HIV-prevention interventions since the beginning of the epidemic. Psychol Bull. 2005;131(6):856–897

PII: S0301-2115(07)00430-7

doi: 10.1016/j.ejogrb.2007.09.010

European Journal of Obstetrics & Gynecology and Reproductive Biology
Volume 136, Issue 2 , Pages 137-145 , February 2008

Article Tools